Eagle Health Investments
Latest statistics and disclosures from Eagle Health Investments's latest quarterly 13F-HR filing:
- Top 5 stock holdings are NTRA, ICLR, ILMN, UTHR, DXCM, and represent 43.22% of Eagle Health Investments's stock portfolio.
- Added to shares of these 10 stocks: RARE (+$14M), CRSP (+$13M), GH (+$13M), EXAS (+$8.4M), TXG (+$5.1M), HOWL, VKTX, PACB, UTHR, INSP.
- Started 6 new stock positions in EXAS, VKTX, RARE, CRSP, TXG, HOWL.
- Reduced shares in these 10 stocks: ALNY (-$13M), IQV (-$13M), SRPT (-$11M), DHR (-$11M), ADPT (-$6.0M), NTRA (-$5.3M), ICLR (-$5.2M), DXCM, ISRG, TMDX.
- Sold out of its position in ADPT.
- Eagle Health Investments was a net seller of stock by $-5.4M.
- Eagle Health Investments has $538M in assets under management (AUM), dropping by 9.37%.
- Central Index Key (CIK): 0001842545
Tip: Access up to 7 years of quarterly data
Positions held by Eagle Health Investments consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Eagle Health Investments
Eagle Health Investments holds 27 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Natera (NTRA) | 10.8 | $58M | -8% | 633k | 91.46 |
|
| Icon SHS (ICLR) | 9.3 | $50M | -9% | 150k | 335.95 |
|
| Illumina (ILMN) | 8.1 | $44M | 319k | 137.32 |
|
|
| United Therapeutics Corporation (UTHR) | 7.7 | $41M | +5% | 180k | 229.72 |
|
| Dex (DXCM) | 7.3 | $40M | -7% | 285k | 138.70 |
|
| Argenx Se Sponsored Adr (ARGX) | 6.2 | $33M | 85k | 393.72 |
|
|
| Iqvia Holdings (IQV) | 5.7 | $31M | -29% | 122k | 252.89 |
|
| Danaher Corporation (DHR) | 5.3 | $28M | -27% | 114k | 249.72 |
|
| Inspire Med Sys (INSP) | 4.9 | $26M | +7% | 122k | 214.79 |
|
| Transmedics Group (TMDX) | 3.8 | $21M | -11% | 279k | 73.94 |
|
| Procept Biorobotics Corp (PRCT) | 3.1 | $17M | 337k | 49.42 |
|
|
| Guardant Health (GH) | 2.8 | $15M | +507% | 730k | 20.63 |
|
| 4d Molecular Therapeutics In (FDMT) | 2.7 | $15M | +5% | 463k | 31.86 |
|
| Intuitive Surgical Com New (ISRG) | 2.6 | $14M | -17% | 36k | 399.09 |
|
| Ultragenyx Pharmaceutical (RARE) | 2.6 | $14M | NEW | 300k | 46.69 |
|
| Crispr Therapeutics Namen Akt Put Option (CRSP) | 2.5 | $13M | NEW | 197k | 68.16 |
|
| Sarepta Therapeutics (SRPT) | 2.5 | $13M | -45% | 103k | 129.46 |
|
| Fusion Pharmaceuticals (FUSN) | 2.3 | $12M | 580k | 21.32 |
|
|
| Agios Pharmaceuticals (AGIO) | 1.8 | $9.7M | 331k | 29.24 |
|
|
| EXACT Sciences Corporation (EXAS) | 1.6 | $8.4M | NEW | 121k | 69.06 |
|
| Pacific Biosciences of California (PACB) | 1.5 | $8.1M | +42% | 2.2M | 3.75 |
|
| Alnylam Pharmaceuticals (ALNY) | 1.3 | $7.2M | -64% | 48k | 149.45 |
|
| 10x Genomics Cl A Com (TXG) | 0.9 | $5.1M | NEW | 135k | 37.53 |
|
| Werewolf Therapeutics (HOWL) | 0.8 | $4.5M | NEW | 700k | 6.48 |
|
| Viking Therapeutics (VKTX) | 0.7 | $3.7M | NEW | 45k | 82.00 |
|
| Immunocore Hldgs Ads (IMCR) | 0.6 | $3.0M | 46k | 65.00 |
|
|
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 0.5 | $2.7M | 43k | 62.24 |
|
Past Filings by Eagle Health Investments
SEC 13F filings are viewable for Eagle Health Investments going back to 2020
- Eagle Health Investments 2024 Q1 filed May 14, 2024
- Eagle Health Investments 2023 Q4 filed Feb. 12, 2024
- Eagle Health Investments 2023 Q3 filed Oct. 27, 2023
- Eagle Health Investments 2023 Q2 filed Aug. 14, 2023
- Eagle Health Investments 2023 Q1 filed May 12, 2023
- Eagle Health Investments 2022 Q4 filed Feb. 13, 2023
- Eagle Health Investments 2022 Q3 filed Nov. 14, 2022
- Eagle Health Investments 2022 Q2 filed Aug. 11, 2022
- Eagle Health Investments 2022 Q1 filed May 12, 2022
- Eagle Health Investments 2021 Q4 filed Feb. 10, 2022
- Eagle Health Investments 2021 Q3 filed Oct. 20, 2021
- Eagle Health Investments 2021 Q2 filed July 19, 2021
- Eagle Health Investments 2021 Q1 filed April 23, 2021
- Eagle Health Investments 2020 Q4 filed Feb. 4, 2021